XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Inventories (Tables)

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Schedule of Inventory, Current

At March 31, 2024 and December 31, 2023, the Company's net inventories consisted of the following:

						March 31, 2024						December 31, 2023
Raw materials and work in process						$	12,772,140					$	12,619,092
Consigned inventory						231,264						149,701
Finished goods						4,240,018						4,645,098
Total inventories						17,243,422						17,413,891
less non-current inventories						(12,915,896)						(12,804,529)
Total inventories classified as current						$	4,327,526					$	4,609,362

Schedule of Inventory, Noncurrent

At March 31, 2024 and December 31, 2023, the Company's non-current inventories consisted of the following:

						March 31, 2024						December 31, 2023
Vibativ Raw Materials						$	6,611,426					$	6,611,426
Kristalose Raw Materials						3,213,387						3,263,516
Vaprisol Conivaptan Raw Materials						1,173,442						1,170,641
Sancuso Raw Materials						578,804						574,502
Caldolor Raw Materials						31,489						—
Acetadote Raw Materials						25,048						33,678
Study Drug Ifetroban Raw Materials						203,383						203,383
Vibativ Finished Goods						955,969						810,454
Caldolor Finished Goods						53,326						67,307
Omeclamox						69,622						69,622
Total inventories classified as non-current						$	12,915,896		12915896			$	12,804,529

X

- References

No definition available.

+ Details

Name:	us-gaap_InventoryDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483489/210-10-50-1

+ Details

Name:	us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle including inventoried costs relating to long-term contracts or programs.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfInventoryNoncurrentTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration